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Abstract 
Inflammation is an established etiopathogenesis factor of infantile spasms (IS), a therapy-resistant epileptic 
syndrome of infancy. We investigated the IS-associated transcriptomic alterations of neurotransmission 
in rat hypothalamic arcuate nucleus, how they are corrected by antiinflamatory treatments and whether 
there are sex differences. IS was triggered by repeated intraperitoneal administration of N-methyl-D-as- 
partic acid following anti-inflammatory treatment (adreno-cortico-tropic-hormone (ACTH) or PMX53) 
or normal saline vehicle to prenatally exposed to betamethasone young rats. We found that treatments 
with both ACTH and PMX53 resulted in substantial recovery of the genomic fabrics of all types of synaptic 
transmission altered by IS. While ACTH represents the first line of treatment for IS, the even higher effi- 
ciency of PMX53 (an antagonist of the complement C5a receptor) in restoring the normal transcriptome 
was not expected. In addition to the childhood epilepsy, the recovery of the neurotransmission genomic 
fabrics by PMX53 also gives hope for the autism spectrum disorders that share a high comorbidity with IS. 
Our results revealed significant sex dichotomy in both IS-associated transcriptomic alterations (males more 
affected) and in the efficiency of PMX53 anti-inflammatory treatment (better for males). Our data further 
suggest that anti-inflammatory treatments correcting alterations in the inflammatory transcriptome may 
become successful therapies for refractory epilepsies. 
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Infantile spasms (IS; West syndrome; also epileptic spasms 
during infancy first described by Dr. West in 1841) is a 
severe epileptic encephalopathy of infancy. Etiology of IS  
is quite complex and still not fully understood. Infantile 
spasms are characterized by a triad of brief spastic seizures, 
large amplitude asynchronous waves in the electroencepha- 
lography (EEG) recordings (hypsharrhythmia) and mental 
deterioration underlying the seriousness of this condition. 
Despite many years of investigation, the complete therapeu- 
tic solution for infantile spasms is far from available. Infan- 
tile spasms have also significant (up to 30%) comorbidity 
with autism spectrum disorders (ASD). Because of this close 
link, an effective treatment of IS covering common etio- 
pathogenesis with ASD (such as neuroinflammation Ohja et 
al, 2018) may contribute a treatment option for ASD as well. 
Neuroinflammation has been established as one of the con- 
tributors to the pathophysiology of epilepsy (Aronica et al., 
2017). In both experimental animals and human patients, 
transcriptomic analysis of different seizure types and epilep- 
sies indicates significant changes in profiles of inflammatory 
transcriptome as well as the transcriptome pertinent for 
synaptic transmission (Laurén et al., 2010; Das et al., 2012). 
Tuberous sclerosis (a condition resulting from TSC1 or 
TSC2 gene mutations and characterized by occurrence of 
neuroectodermal tubers) in humans is frequently associated 
with infantile spasms that progress to other types of epilep- 
sy. Patients with tuberous sclerosis have increases expression 
of cell adhesion and inflammatory genes in the tubers plus 
wide disarray of gene expression including genes involved 
in synaptic transmission in the perituberal tissue (Boer et  
al., 2010). Hence, we were interested in rodent models of 
seizures and epilepsy, how transcriptomic profiles would 
change as a function of seizure type, sex, and developmental 
stage of the animal and whether treatments affecting inflam- 
mation can stabilize transcriptomic profiles of genes belong- 
ing to synaptic transmission. 
In two previous papers (Iacobaş et al., 2013, 2018a) we an- 
alyzed the alterations of the gene expression profiles in the 
hypothalamic arcuate nucleus of our rat model of IS (Velíšek 
et al., 2007). These papers are part of our larger effort to un- 
derstand the impact and commonalities of different forms  
of epilepsy on the transcriptomes in  various brain areas.  In 
addition to the arcuate nucleus in the IS model, we have also 
profiled the CA1 (Friedman et al., 2013) and dentate gyrus 
(Velíšková et al., 2015, 2017; Iacobaş et al., 2018b) regions 
of the hippocampus involved in other models of seizures 
and epilepsy. We have studied also the protective role of 
estrogen against the seizure-induced neuronal injury 
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in the hippocampus (Velíšková et al., 2015, 2017; Iacobaş et 
al., 2018b). Data from the paraventricular nucleus and the 
prefrontal cortex in the animal model of IS following ACTH 
and PMX53 treatments are yet to be published. 
We have had particular interest in how the spasms in our 
model can affect the transcriptomic networks responsible for 
the glutamatergic (denoted by GLU), GABAergic (GABA), 
dopaminergic (DA), cholinergic (ACH) and serotonergic 
(5HT) neurotransmission. Genes pertaining to each type of 
neurotransmission were selected using Kyoto Encyclopedia 
of Genes and Genomes developed by Kanehisa Laboratories 
(http://www.genome.jp). While the impairment of neuro- 
transmission can significantly contribute to the expression 
of spasms, the neurotransmission recovery may become a 
measure (marker) of treatment efficacy. This is particularly 
important as current treatments of infantile spasms (adre- 
nocorticotropic hormone-ACTH, corticosteroids and vigab- 
atrin) are only partially effective (less than 55% efficacy after 
one year), leaving many infants and their families without 
hope for improvement in future. 
In our two-hit IS rat model (Velíšek et al., 2007; Yum 
et al., 2012), the animals were prenatally primed with two 
doses of betamethasone delivered intraperitoneally to preg- 
nant dams (control animals received saline). The spasms in 
infant, betamethasone-primed, rats were postnatally trig- 
gered by repeated intraperitoneal administration of N-meth- 
yl-D-aspartic acid (NMDA). After the first bout of spasms 
on postnatal day (P) 12, the rats were randomized into treat- 
ment groups or received vehicle (saline). Treatment delivery 
and spasm trigger continued through P14 and P15, respec- 
tively. On P15, rats were anesthetized and brain regions of 
interest were collected. Hypothalamic arcuate nucleus was 
selected as the main region of interest because our previous 
study indicated its prominent activation during experimental 
spasms (Velíšek et al., 2007). Arcuate nuclei of both sexes 
were profiled using Agilent two-color 4x44k gene expres- 
sion microarrays and our optimized protocol (Iacobaş et al., 
2018a), with 4 biological replicas of each condition (20 males 
and 20 females randomly distributed in 5 sex homogeneous 
groups). Raw data and full description of the experimental 
protocol are available as GSE81061 and GSE84585 at http:// 
www.ncbi.nlm.nih.gov/geo. 
Since  no  neurotransmission gene  was  differently ex- 
pressed between males and females in control rats (SNS; sa- 
line (S)-primed, no (N) induced spasms, postnatally injected 
with saline (S)) we asked what transcriptomic feature might 
explain the known behavioral sex differences. The response 
came from our genomic fabric paradigm (Iacobaş, 2016) 
that does not limit the characterization of the transcriptome 
to the expression levels of individual genes but considers 
also their expression control and coordination with expres- 
sion of each other gene. By definition, the genomic fabric  
of a functional pathway is the transcriptome associated to 
the most interconnected and stably expressed gene network 
responsible for that biological function. Thus, the pair-wise 
relevance analysis (that takes into account the contributions 
off all gene-pairs to the expression level, control and coordi- 
nation to the neurotransmission transcriptomic landscape) 
has shown substantial differences between the two sexes 
(Figure 8 in Iacobaş et al., 2013). Years of working with 
animal models taught us that prenatal priming with beta- 
methasone is not only essential for ACTH efficacy against 
experimental spasms but it also increases the propensity of 
rats to develop spasms after the NMDA trigger (Velíšek et 
al., 2007). This pathophysiological finding can be explained 
by the major alterations of the pair-wise relevant topology of 
the genomic fabrics of the synaptic pathways in response to 
the betamethasone priming. 
Data in our randomized study of induced spasms clearly 
showed that male pups displayed more spasms at the end of 
the experiment compared to females. Indeed, the microar- 
ray analyses indicated that the transcriptomic effects of the 
induced spasms on the neurotransmission are sex specific, 
on average 3× larger in males than in females (Iacobaş et al., 
2018a). In addition to the percentage of the regulated genes, 
we have evaluated the transcriptomic alterations using the 
novel Weighted Pathway Regulation analysis that takes into 
account all genes regardless of whether they were considered 
as significantly regulated (according to arbitrarily intro- 
duced cut-offs). Further analysis determined that in males, 
specifically GABA pathway transcriptome was significantly 
impaired, while in females, the DA pathway was affected the 
most by the spasms. 
In the set of experiments with treatments, the betameth- 
asone-primed (B) rats after the first trigger of spasms (Y) 
were randomized into treatment groups treated either with 
full molecule of rat ACTH (BYA group), PMX53 (BYP 
group) or Saline (BYS group). ACTH (adrenocorticotropic 
hormone) is the FDA-approved first line of treatment for 
epileptic spasms in human infancy (Knupp et al., 2016). 
PMX53, an antagonist of the C5a receptor, was suggested as 
an alternative because of the positive results with this drug 
in other models of epilepsy (Benson et al., 2015). Rationale 
for using PMX53 was that neuroinflammation, including 
that regulated via innate immune complement activation 
through C5ar1, is significantly involved in both epilepsy and 
ASD (Aronica et al., 2017; Ohja et al., 2018). Inhibition of 
C5ar1 decreases production of tumor necrosis factor alpha 
(TNFα), one of the key pro-inflammatory molecules respon- 
sible for microglial activation leading to neuronal damage 
and hyperexcitability. Thus, by attenuation of neuroinflam- 
mation, PMX53 might improve excitatory/inhibitory bal- 
ance, which is impaired in epilepsy (Benson et al., 2015) and 
also in ASD. Since both infantile spasms and ASD have male 
predominance (male:female ratio is approximately 1.5:1 in 
infantile spasms and 3–4:1 in ASD), we evaluated males and 
females separately and then compared the results. 
After treatment (ACTH or  PMX53) we  noticed  a  sig- 
nificant suppression of spasms in males, but not as much    
in females with respect to the corresponding betametha- 
sone-primed pups with spasms, “treated” with saline only 
(the BYS group). PMX53 had at least equal if not better 
effects as ACTH on the suppression of spasms in males. It 
should be noted here that we evaluated only those animals 
entering the transcriptomic analysis (4 from each group) 
hence the cohort size was small and could have contributed 
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Figure 1 Experimental spasms alter the cholinergic transmission genes but both adreno-cortico-tropic-hormone (ACTH) and PMX53 
treatments partially restore their normal expression. 
In the set of experiments with treatments, the betamethasone-primed (B) rats after the first trigger of spasms (Y) were randomized into treatment 
groups treated either with full molecule of rat ACTH (BYA group), PMX53 (BYP group) or Saline (BYS group). (A, B) (log2) expression levels of 
cholinergic genes in BYS, BYA and BYP plotted against (log2) expression levels in non-spasm values (BNS). In these diagrams, the representative 
points of the unaltered genes (same expression as in BNP) are located on the diagonal. Note that expression levels in BYA (blue dots) and BYP (green) 
are significantly closer to those in BNS than expression levels in BYS (red) in both males (A) and females (B). (C) Average % square deviation of the 
expression of cholinergic genes from the BNS in male and female rats. Note that males were more affected by the spasms (larger average square devi- 
ation) but also benefit significantly more from the treatments (larger reduction of the average % square deviation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
to the lack of statistical significance for ACTH and PMX53 
effects in females. The microarray experiment confirmed 
that both treatments (ACTH or PMX53) contributed to sig- 
nificant restoration of the synaptic pathway transcriptomes 
and the relative effect was larger in males. In the 2018 treat- 
ment paper (Iacobaş et al., 2018a), the effect was evaluated 
both by the reduction of percentage of regulated genes, and 
by the recently introduced pathway restoration efficiency 
(Iacobaş et al., 2018c). However, the same conclusion can 
be drawn by using several other quantifiers. For instance,   
as illustrated in Figure 1A and B by plotting the (log2) ex- 
pression values in BYS, BYA and BYP conditions against 
the corresponding values in BNS condition there were more 
alterations but also more regenerations following the treat- 
Figure 2 Remodelling of the 
cholinergic transmission gene 
networks. 
In the set of  experiments with  t 
re atments,  the b et amet ha - 
sone-primed (B) rats after the 
first trigger of spasms (Y) were 
randomized into treatment groups 
treated either with full mole- 
cule of rat ACTH (BYA group), 
PMX53 (BYP group) or Saline 
(BYS group). (A) Part of the path- 
way regulated by the activation 
of the cholinergic receptors of 
the presynaptic and postsynaptic 
neurons. M2/4: Muscarinic me- 
tabotropic acetylcholine receptors 
( Chrm 2 / 4 ) ; Gi/o: G- proteins 
(Gnai1/2/3, Gnao1, Gnb1/2/3/4/5, 
Gng10/11/12/13/3/5/7/8); VCCC: 
voltage-dependent calcium chan- 
nels (Cacna1a/b); AC: adenylate 
cyclases  (Adcy2/3/4/5/7/8/9). (B– 
E) Gene expression correlation in 
the SNS (the absolute control: not 
betamethasone-primed no spasms 
pups treated with saline), BNS, 
BYS, BYA and BYP conditions. 
 
ments in males than in females. In Figure 1C we used the 
average square deviation from the non-spasm value to eval- 
uate alteration in animals with spasms treated with ACTH 
(BYA), PMX53 (BYP) or just saline (BYS). 
We have also obtained interesting results in the coordi- 
nation analysis (Iacobaş and Iacobaş, 2010) of the synapse 
genes in each of the five groups of rats (BYS, BYA, BYP, 
BNS, SNS). In this analysis, two genes were considered as 
synergistically expressed if the abundances of their tran- 
scripts increase or decrease simultaneously within biolog- 
ical replicas (the four animals of the group). The genes are 
antagonistically expressed if their levels manifest opposite 
tendencies and independently expressed if the variation of 
one gene has no effect on the other’s level. Thus, we found 
A B C 
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that the transcriptomic networks by which the expressions 
of genes synchronize to ensure the “transcriptomic stoi- 
chiometry” (Iacobaş et al., 2007) of the synaptic functional 
pathways can be impaired by spasms and partially restored 
by the anti-spasm treatments. 
Figure 2 represents the transcriptomic network, by which 
activated cholinergic receptors control the synaptic trans- 
mission in the arcuate nucleus of the male rat in each of the 
five conditions. In Figure 2, a red/blue line indicates that the 
connected genes are (P-value < 0.05) significantly synergis- 
tically/antagonistically expressed in that condition. Missing 
connecting lines indicate not enough statistical evidence for 
expression coordination. Of note is the substantial remodel- 
ling of the gene networks by prenatal exposure to betameth- 
asone (compare BNS with SNS). Further, the seizure induc- 
tion decoupled the cholinergic receptors from the G-proteins 
in (BYS) and that the anti-spasms treatments (BYA and 
BYP) restored most of this coupling. The results were simi- 
lar for all neurotransmission types in both male and female 
rats. This profound remodelling of the neurotransmission 
genomic fabrics clearly shows how sensitive the synapse-me- 
diated brain circuitries are to the neurological diseases and 
treatments addressing these diseases. 
Conclusions 
The brain circuitry is continuously rebuilding (regenerating) 
itself, responding with remodeling of the neurotransmission 
transcriptome to the induced spasms and recovering in re- 
sponse to treatment of spasms. We determined that atten- 
uation of neuroinflammation with PMX53 may become an 
effective treatment approach for infantile spasms, which may 
additionally improve comorbidity of infantile spasms with the 
ASD. Using novel transcriptome analytical tools developed on 
the genomic fabric paradigm (Iacobaş, 2016), we determined 
that treatment efficacy (in both ACTH and PMX53) is associ- 
ated with significant transcriptomic regeneration of synaptic 
pathways and can inform about possible efficacy of treatments. 
We also determined sex specificity of transcriptome changes 
and recovery which adds another dimension to the develop- 
mental profile of changes after seizures (Azevedo et al., 2018). 
Our novel tools improved quantification measures of both 
alterations and recovery of the synaptic neurotransmission 
transcriptome in the model of infantile spasms. 
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